Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cantargia AB (DE:7V3)
FRANKFURT:7V3
Holding DE:7V3?
Track your performance easily
7V3 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.21 - €0.46
Previous Close€0.23
Volume0.00
Average Volume (3M)5.00K
Market Cap
€50.82M
Enterprise Value€6.93M
Total Cash (Recent Filing)kr496.52M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta1.00
Next Earnings
Nov 15, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume5,000
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
7V3 FAQ
What was Cantargia AB’s price range in the past 12 months?
Cantargia AB lowest stock price was €0.21 and its highest was €0.46 in the past 12 months.
What is Cantargia AB’s market cap?
Currently, no data Available
When is Cantargia AB’s upcoming earnings report date?
Cantargia AB’s upcoming earnings report date is Nov 15, 2024 which is in 40 days.
How were Cantargia AB’s earnings last quarter?
Cantargia AB released its earnings results on Aug 28, 2024. The company reported -€0.021 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.021.
Is Cantargia AB overvalued?
According to Wall Street analysts Cantargia AB’s price is currently Overvalued.
Does Cantargia AB pay dividends?
Cantargia AB does not currently pay dividends.
What is Cantargia AB’s EPS estimate?
Cantargia AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cantargia AB have?
Cantargia AB has 183,686,690 shares outstanding.
What happened to Cantargia AB’s price movement after its last earnings report?
Cantargia AB reported an EPS of -€0.021 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.125%.
Which hedge fund is a major shareholder of Cantargia AB?
Currently, no hedge funds are holding shares in DE:7V3
---
Cantargia AB Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Cantargia AB
Cantargia AB is engaged in the development of products used in the treatment of cancer. It has developed specific antibodies against IL1RAP to treat serious, life-threatening diseases. The company's first product candidate, CAN04, has also been designed to treat different forms of cancer, with the initial focus on the treatment of non-small cell lung cancer and pancreatic cancer.
---
Technical Analysis
---